Irbesartan hydrochloride
Based on 8 publication(s) in Google Scholar
Irbesartan (SR-47436) hydrochloride is an orally active Ang II type 1 (AT1) receptor blocker (ARB). Irbesartan hydrochloride can relax the blood vessels, low blood pressure and increase the supply of blood and oxygen to the heart. Irbesartan hydrochloride can be used for the research of high blood pressure, heart failure, and diabetic kidney disease.
For research use only. We do not sell to patients.
- CAS No.: 329055-23-4
- Formula: C25H29ClN6O
- Molecular Weight:464.99
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications Citing Use of MedChemExpress (MCE) Irbesartan hydrochloride
More- J Exp Clin Cancer Res. 2023 May 4;42(1):111. [Abstract]
- J Immunother Cancer. 2026 Mar 25;14(3):e012426. [Abstract]
- Int J Biol Macromol. 2024 May;266(Pt 1):131175. [Abstract]
- Phytother Res. 2026 Feb;40(2):812-828. [Abstract]
- Atherosclerosis. 2019 Sep:288:124-136. [Abstract]
- Biomedicines. 2021 Dec 2;9(12):1820. [Abstract]
- FASEB J. 2026 Jan 31;40(2):e71433. [Abstract]
- Saudi Pharm J. 2022 Mar;30(3):237-244. [Abstract]
-
WB
-
Cell Imaging/Staining
-
In Vivo Efficacy Study
-
IF
-
IF
All Angiotensin Receptor Isoforms
More
Biological Activity
Irbesartan hydrochloride (20 μM, 3 h) reduces Th22 cells chemotaxis in vitro[1].
Irbesartan hydrochloride (0 μM, 20 μM, 40 μM and 60 μM) suppresses Th22 cells differentiation in vitro[1].
Irbesartan hydrochloride (20 μM) inhibits Th22 cells related proinflammatory response of TECs in vitro[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:CD4+ T cells
-
Concentration:0, 20, 40 and 60 μM
-
Incubation Time:48 h
-
Result:Exerted no obvious effect on viability of CD4+T cells.
Irbesartan hydrochloride (oral gavage; 50 mg/kg/d; once daily) exerts obvious renoprotective effects[1].
Irbesartan hydrochloride (oral gavage; 50 mg/kg/d; once daily) relieves systemic inflammation and renal fibrosis in hypertension mice induced by Ang II[1].
Irbesartan hydrochloride (20 μM; for 3 h) can attenuate Th22 cells recruitment and IL-22 secretion, which might be through inhibiting chemotaxis in hypertensive renal injury mice[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:C57BL/6 mice[1]
-
Dosage:50 mg/kg
-
Administration:oral gavage; 50 mg/kg/d; once daily
-
Result:Displayed low Th22 cells and IL-22, exerted similar inhibitory effect on Th1 cell proportion and displayed decreased IL-22 level in kidney.
Prevented BP elevation markedly and decreased urinary albumin/creatinine ratio, BUN and Scr.
Repressed the expression of IL-1β, IL-6, TNF-α, α-SMA, FN and Col I and diminished the extent of fibrosis.
-
Animal Model:C57BL/6 mice[1]
-
Dosage:20 μM
-
Administration:20 μM; for 3 h
-
Result:Downregulated renal CCL20, CCL22 and CCL27 concentrations.
Chemical Information
-
CAS No. 329055-23-4
-
Molecular Weight 464.99
-
Formula C25H29ClN6O
-
SMILES
O=C1N(CC2=CC=C(C3=C(C4=NN=NN4)C=CC=C3)C=C2)C(CCCC)=NC15CCCC5.[H]Cl
-
Synonyms
SR-47436 hydrochloride; BMS-186295 hydrochloride
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications (8)
-
Journal Impact Factor
-
Most Recent
-
J Exp Clin Cancer Res
Irbesartan overcomes gemcitabine resistance in pancreatic cancer by suppressing stemness and iron metabolism via inhibition of the Hippo/YAP1/c-Jun axis. [Abstract]2023 May 4;42(1):111. PMID: 37143164
Irbesartan hydrochloride purchased from MedChemExpress. Usage Cited in: J Exp Clin Cancer Res. 2023 May 4;42(1):111. [Abstract]
The apoptosis of organoids treated with GEM (0.8 μM) and Irbesartan (1 μM) for 72 h was determined by western blot for cleaved-caspase 3/7. Tubulin was used as loading control.
Irbesartan hydrochloride purchased from MedChemExpress. Usage Cited in: J Exp Clin Cancer Res. 2023 May 4;42(1):111. [Abstract]
Organoids were treated with vehicle, GEM (0.8 μM), irbesartan (1 μM) and GEM (0.8 μM) plus irbesartan (1 μM), followed by continually monitoring PDAC organoid apoptosis by real-time caspase3/7 probe imaging for 72 h.
Irbesartan hydrochloride purchased from MedChemExpress. Usage Cited in: J Exp Clin Cancer Res. 2023 May 4;42(1):111. [Abstract]
Irbesartan (20 mg/kg; po; twice a week) plus GEM significantly reduced the weight of pancreatic tumor.
Irbesartan hydrochloride purchased from MedChemExpress. Usage Cited in: J Exp Clin Cancer Res. 2023 May 4;42(1):111. [Abstract]
Irbesartan (20 mg/kg; po; twice a week) induced apoptosis in mouse pancreatic tumor tissues.
Irbesartan hydrochloride purchased from MedChemExpress. Usage Cited in: J Exp Clin Cancer Res. 2023 May 4;42(1):111. [Abstract]
Irbesartan (20 mg/kg; po; twice a week) decreased the percent of Ki67 positive cells in mouse pancreatic tumor tissues.
-
J Immunother Cancer
Telmisartan increases olaparib efficacy in homologous recombination proficient tumors by augmenting type I interferon production. [Abstract]2026 Mar 25;14(3):e012426. PMID: 41881499 -
Int J Biol Macromol
An injectable polyacrylamide/chitosan-based hydrogel with highly adhesive, stretchable and electroconductive properties loaded with irbesartan for treatment of myocardial ischemia-reperfusion injury. [Abstract]2024 May;266(Pt 1):131175. PMID: 38552696 -
Phytother Res
Saikosaponin D Regulates HK2-Mediated Glycolytic Lactate Signaling to Alleviate CKD-Induced Renal Fibrosis. [Abstract]2026 Feb;40(2):812-828. PMID: 41508401 -
Atherosclerosis
RhoGDI stability is regulated by SUMOylation and ubiquitination via the AT1 receptor and participates in Ang II-induced smooth muscle proliferation and vascular remodeling. [Abstract]2019 Sep:288:124-136. PMID: 31362179 -
Biomedicines
2021 Dec 2;9(12):1820. PMID: 34944635 -
FASEB J
Hirudin Ameliorates Kidney Injury in DKD Mice by Decreasing SOD2 β-Hydroxybutyrylation Mediated ROS Level and NLRP3 Inflammasome Formation. [Abstract]2026 Jan 31;40(2):e71433. PMID: 41546551 -
Saudi Pharm J
Study of influence of Catha edulis (Khat) chewing on oral pharmacokinetics of irbesartan in rats using a newly developed HPLC-UV method. [Abstract]2022 Mar;30(3):237-244. PMID: 35498225
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)